Clinical Trial Update: Clinical Study of Dexmedetomidine Administered Intranasally to Relieve Perioperative Anxiety and Depression in Patients With Colorectal Tumors [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating intranasal dexmedetomidine to relieve perioperative anxiety and depression in patients with colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: First Affiliated Hospital of Chongqing Medical University | Conditions: Colorectal Cancer | Phase 3 | Status: RECRUITING